Characteristics
- Proprietary hardware and software with patent protection
- Specific for cancer-contrasting, highly fluorescent and non-toxic dye, fluorescein (FDA-approved for clinical applications)
- Real-time performance with dual-imaging (regular and fluorescence) capability
- Modular upgrade design for conventional endoscopic imaging systems
- Superior to auto-fluorescence methods in sensitivity and specificity
- Suitable for surface and non-pigmented lesion detection, accounting for over 80% of adult cancers
- Wide applications in early cancer detection, optical biopsy, and surgical treatment
- Potentially life-saving tool in cancer diagnosis, treatment and prognosis
- High-performance and cost-effective device for patients, hospitals, and insurance companies
|
